Qube Research & Technologies (QRT)
CODX

Qube Research & Technologies (QRT)’s Co-Diagnostics CODX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– -$16 – 3423
2024
Q2 		– Hold
0
– – – 3589
2024
Q1 		– Hold
0
– – – 4280
2023
Q4 		– Hold
0
– – – 4138
2023
Q3 		– Hold
0
– – – 3905
2022
Q4 		– Sell
-908
Closed -$87K – 2538
2022
Q3 		$87K Buy
908
+143
+19% +$20K ﹤0.01% 2006
2022
Q2 		$129K Sell
765
-89
-10% -$13.5K ﹤0.01% 1852
2022
Q1 		$158K Buy
+854
New +$177K ﹤0.01% 1996
2021
Q3 		– Sell
-1,144
Closed -$283K – 2280
2021
Q2 		$283K Buy
1,144
+370
+48% +$95.1K ﹤0.01% 1612
2021
Q1 		$222K Buy
+774
New +$309K ﹤0.01% 1611
2020
Q2 		– Sell
-1,316
Closed -$301K – 1743
2020
Q1 		$301K Buy
+1,316
New +$228K 0.01% 724

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CODX Position: Q3 2024 in Review

Qube Research & Technologies (QRT) held its Co-Diagnostics (CODX) position steady in Q3 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3423.

Qube Research & Technologies (QRT) first reported a position in CODX in Q1 2020 and has held it in 6 quarters since. The position peaked at $301K in Q1 2020. 36 funds tracked by Wall St. Rank hold CODX as of Q3 2024.

  • Qube Research & Technologies (QRT) held 0 shares of Co-Diagnostics worth $0 as of Q3 2024.
  • Qube Research & Technologies (QRT) left its Co-Diagnostics share count unchanged in Q3 2024.
  • Co-Diagnostics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2024, its #3423 holding.
  • Qube Research & Technologies (QRT) first reported a position in Co-Diagnostics in Q1 2020 and has held it in 6 quarters since.
  • Qube Research & Technologies (QRT)'s Co-Diagnostics position peaked at $301K in Q1 2020.
  • 36 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.